Harnessing Magnetic Beads in Immunodiagnostics
eBook
Published: August 8, 2025

Credit: iStock
Immunodiagnostics is central to disease detection, therapeutic monitoring and biomarker identification.
The use of magnetic beads can streamline protein purification and boost immunoassay performance. Yet, nonspecific binding, optimization of bead-to-sample ratios and assay sensitivity remain persistent challenges. Addressing these is critical to improving diagnostic accuracy and efficiency.
This eBook explores how magnetic beads improve immunodiagnostic workflows, from protein purification to advanced immunoassays, while providing practical guidance to optimize performance.
Download this eBook to discover:
- How magnetic beads enhance sensitivity and speed in immunoassays
- Strategies for overcoming binding and assay optimization challenges
- Protocol tips and bead selection guidance for diagnostic applications
ebook
Harnessing
magnetic beads in
immunodiagnostics
How magnetic beads can be used to streamline
protein purification and enhance immunoassays
Immunodiagnostics has been a game changer for healthcare. It’s at the heart of
disease detection, therapeutic monitoring, and biomarker identification. In the last few
years, immunodiagnostics has advanced even further with the help of magnetic beads.
These humble, yet powerful tools assist in protein purification and immunoassays,
enhancing both assay sensitivity and speed. In immunoassays, magnetic beads
can separate, detect, and quantify a whole range of molecules including target
proteins, antibodies, and antigens. Essentially, they offer an easier and more effective
alternative to traditional protein separation methods.
Magnetic beads are particularly beneficial in complex diagnostic tests such
as multiplexed assays. When coated with specific antibodies, magnetic beads
selectively bind to target proteins and antigens. This binding creates high-purity
samples that are easy to isolate through a magnetic field.
With these broad benefits in mind, this e-book will explore the use of magnetic
beads in mmunodiagnostics, focusing on protein purification and immunoassay
applications. Delve into the key benefits and challenges of magnetic beads across
these applications and find protocol tips and magnetic bead recommendations.
Fig 1. The biotinylated primary
antibody is incubated with the beads
and binds to them. This target binds
to the antibody.
2
Optimizing protein
purification with
magnetic beads
Protein purification without antibodies
Magnetic beads are revolutionizing protein purification processes. They can
efficiently isolate and purify target proteins (or protein complexes) from a wide range
of samples and volumes. The adaptability of magnetic bead surfaces for different
functions provides unparalleled flexibility when purifying proteins. For example,
magnetic beads such as His Mag Sepharose™ Ni beads can be used to purify Histagged proteins, enhancing standard nickel ion affinity chromatography.
There are many additional magnetic bead conjugation options available. For instance,
they can come either preconjugated with surface ligands such as antigens, enzymes,
or peptides, or you can select coated magnetic beads with specific surface chemistry
to conjugate with your specific ligands.
Magnetic beads are widely used across many different protein purification
applications. For example, you can get magnetic beads conjugated with protein A
or protein G, such as Protein A Mag Sepharose Xtra beads. These beads (see Fig 2)
are commonly used for purifying IgG antibodies but can also be used to purify
polyclonal and monoclonal antibodies. In a recent 2024 study, researchers used
Protein A magnetic beads to develop a one-step protocol, purifying two monoclonal
antibodies directly from nonclarified, crude plant extracts (1). The study showcases
how magnetic beads can significantly save on time and resources and can improve
protein quality and biological activity via efficient purification.
Magnetic beads with functional carboxylic acid groups are also useful for protein
purification applications. For example, these beads have been conjugated with an
aptamer designed to capture the human anticoagulant serine protease, activated
protein C (APC). Using these conjugated carboxylic acid magnetic beads, highly pure
APC was eluted in its active form, which is highly useful for downstream therapeutic
developments to prevent blood clotting (2).
Another key magnetic bead type for this application is streptavidin-coated magnetic
beads. These beads can be used to purify biotinylated antibodies and proteins such
as glycol-engineered antibodies. These antibodies are widely used for the treatment
of many diseases, including cancers, autoimmune disorders, and inflammatory and
infectious diseases (3).
Antibody-free approaches are useful for high-throughput workflows or when multiple
protein purifications are needed, eliminating time-consuming and costly antibody
production. Magnetic beads make protein purification without antibodies even
faster—and because they’re adaptable to small samples or viscous solutions—they’re
ideal for modern lab workflows.
Fig 2. An illustration of the immunoprecipitation steps using magnetic beads conjugated
with protein A or protein G.
3
Challenges with
magnetic beads in
protein purification
When using magnetic beads for protein purification, one of the main challenges is the
risk of nonspecific binding. Nonspecific binding can occur when using a suboptimal
bead size for the desired target protein or a suboptimal ratio of sample-to-bead
concentration. For example, with a low sample concentration, an excess of available
binding sites on the beads can lead to increased nonspecific binding. Conversely,
for larger proteins, there may be insufficient surface area on the magnetic beads for
effective binding. Also, when using antibodies, not prechecking protein specificity
can also lead to nonspecific binding. To mitigate these challenges, you need to
optimize protein concentration, carefully select appropriate magnetic beads, and
verify the specificity of antibodies prior to use.
Protein purification with antibodies
The use of antibodies immobilized to magnetic beads for protein purification is
termed “magnetic immunoprecipitation.” For this process, an antibody is conjugated
to the surface of the magnetic bead, which is then mixed with the sample containing
the antigen. Alternatively, a secondary antibody could be conjugated to the magnetic
beads, which is then mixed with the sample containing the primary antibody that
is bound to the antigen. Another common method is using proteins like protein A
or protein G conjugated to magnetic beads. These proteins capture the primary
antibody that is bound to the target antigen.
Antibody-coated magnetic beads can provide exceptional specificity for the capture
of the target protein and have been used across a broad range of clinical applications.
For example, they have been used to purify diabetes-associated mutant insulin from
plasma samples (4). More recently, they have been used to purify age-distinct insulin
secretory granules for downstream proteomics and lipidomics analyses (5).
Discover more options for modifying the surface of magnetic beads to suit
your protein purification needs
= Antibody
Protein A/G
Fig 3. Protein A/G magnetic beads are used for antibody isolation applications, including affinity purification
and pull-down, as well as immunoprecipitation. This is due to their surface chemistry which binds lgA and lgG
proteins, features a coating based on lgA/lgG-fusion proteins and offers broad binding capabilities.
4
Workflow and bead selection considerations
1 Optimize bead size, volume, and incubation
times for the target protein
To optimize binding capacity, adjust the bead volume according to the size
and concentration of your target protein. For large target molecules, increase
bead volume to maximize binding sites. Alternatively, you can decrease the
bead size to create more surface area per mass for binding. In workflows using
His-tagged proteins, His Mag Sepharose Ni beads are ideal due to their high
surface area, maximizing binding capacity while reducing nonspecific binding.
When working with low-concentration samples, increasing bead incubation
time can provide more binding opportunities.
2 Adjust elution buffers for recovery and integrity
Optimized elution conditions are essential for recovering pure proteins
and preventing degradation. For protein-specific release, use high-affinity
ligands in your elution buffer, or adjust the pH accordingly. For example, acidic
conditions release proteins from protein A or protein G beads, while imidazole
elution is suited for His-tagged proteins.
3 Carefully prepare buffers to minimize nonspecific binding
Nonspecific interactions can also be reduced with careful buffer preparation.
Blocking agents like BSA, PEG, or glycerol decrease nonspecific binding. Beads
should be equilibrated with a lysis buffer that includes a low concentration
of the blocker, and the same blocker should be added to the wash buffer. To
further reduce background signals, you can preincubate beads in the target
solution without antibodies. You can also perform a pre-step during which
the sample is exposed to beads without the capture molecule. The pre-step
will remove components in the sample that nonspecifically bind to the beads.
The beads without the capture molecule can then be removed and the beads
with the capture molecule can be added to the sample to isolate the protein of
interest.
4 Control temperatures for protein integrity
Conduct binding steps at optimal temperatures to maintain protein stability
and bead integrity. Avoid excessive heating in elution stages, as this can
cause protein denaturation and can lower your binding efficiency. For
some workflows, slower binding at 4°C provides better specificity without
compromising protein integrity.
5
Magnetic immunoassays:
enhancing sensitivity
and speed
While magnetic beads can be used to purify and concentrate proteins prior to
downstream analytical methods, they can also be used directly in magnetic
immunoassays. Benefits of using magnetic beads in immunoassays include improved
assay sensitivity, faster results, and higher specificity, due to the increased surface
area per volume for antigen-antibody interactions.
Magnetic beads are used in various immunoassays, like enzyme-linked
immunosorbent assays (ELISAs), chemiluminescent immunoassays (CLIAs),
fluorescent immunoassays (FIAs), lateral-flow assays (LFAs), and multiplex
immunoassays. Their integration allows for quicker and more efficient antigen
capture, which is crucial in both clinical and research settings.
See how a magnetic immunoassay works to provide
a quick detectable signal
Applications in ELISAs
Magnetic beads are frequently used in ELISAs, including those to detect infectious
diseases. In a 2021 study, nickel ion-coated magnetic beads immobilized SARSCoV-2 antigens containing a His-tag. The antigen-bound magnetic beads were then
incubated with an anti-human IgG antibody conjugated to horseradish peroxidase.
This process enabled the amount of antigen captured to be analyzed. The result
was a chromogenic magnetic immunoassay for SARS-CoV-2 that was both easy
and quick to visually interpret. The detection range is comparable to gold standard
immunoassays (such as traditional ELISA and Luminex) but requires significantly less
time and resources, making it suitable for point-of-care (POC) use (6).
Magnetic beads are also used in more advanced types of ELISAs such as
chemiluminescent ELISAs. These assays offer greater sensitivity and specificity,
especially when detecting low-abundance proteins (7). Magnetic beads coated
with antibodies or protein A/G improve binding kinetics in chemiluminescent
assays, leading to faster protein capture and more accurate signal detection. To
achieve assays with high sensitivity, select assay components, such as Sera-Mag™
SpeedBeads in conjugation with the capture molecule, that enable high assay
specificity while minimizing background noise.
Multiplex immunoassays with magnetic beads
Magnetic beads are invaluable in multiplex immunoassays, which require the
simultaneous detection of multiple biomarkers. By using fluorescent beads with
distinct excitation and emission wavelengths, cross-reactivity can be minimized and
signal clarity improved, even when handling complex samples.
Streptavidin-coated magnetic beads are advantageous for multiplex assays due to their
rapid and highly specific binding to biotinylated antibodies. Commonly used in multiplex
cancer assays, these beads isolate tumor-specific proteins, enabling researchers to track
cancer progression and gain insights into the disease’s development and treatment
response. Non-fluorescently labelled beads can be used and then fluorescently labelled
detection molecules can be used to enable the multiplexing.
Fig 4. Streptavidin-blocked magnetic beads are ideal for high-specificity binding applications, like immunoand molecular diagnostics, as well as NGS library preparation.
6
Challenges and key considerations in
magnetic bead immunoassays
1 Nonspecific binding and signal optimization
Nonspecific binding is a common challenge in immunoassays. In the case of
magnetic immunoassays, magnetic beads can capture unwanted components
alongside the target protein. Solving this issue is essential to achieve high assay
specificity. Optimizing bead surface chemistry and incorporating blocking agents
during washes can prevent unintended interactions and improve target capture
rates. Also, to avoid signal bleed, ensure each biomarker is tagged with beads that do
not interfere with other markers in the assay.
2 Bead-to-antibody ratios and incubation times
Optimizing the bead-to-antibody ratio is crucial for the specificity and sensitivity of
immunoassays. Insufficient antibody concentration can lead to incomplete coverage
of the capture beads, while excess antibodies can produce background noise. The
ratio can be optimized based on assay conditions and sample characteristics, such as
protein size and abundance.
3 Selecting high-affinity and specificity beads and antibodies
To maximize assay performance, select high-affinity beads such as Sera-Mag
Protein A/G, Protein A Mag Sepharose, Protein A Mag Sepharose Xtra, Protein G
Mag Sepharose, and Protein G Mag Sepharose Xtra magnetic beads. These beads
bind selectively to IgG antibodies, allowing target proteins to be captured from
complex samples with minimal off-target interactions. Choosing antibodies with
high specificity also improves binding precision. For high-sensitivity applications,
streptavidin-coated magnetic beads offer strong binding to biotinylated antibodies,
which is particularly useful in multiplex assays.
4 Washing steps for contaminant removal
Washing is a critical step in magnetic immunoassays. Gentle centrifugation or
magnetic washing with buffers containing mild detergents helps remove any
unbound proteins without impacting bead stability or target integrity. A common
protocol involves three washes with phosphate-buffered saline with Tween-20
(PBS-T), which removes unbound proteins while preserving the bead’s magnetic
properties. Avoid excessive washes to reduce the risk of target molecule loss.
5 Handling and storage of magnetic beads
Proper handling techniques should be followed to preserve magnetic bead
functionality and enhance assay performance. Avoid extreme temperatures and use
manufacturer-recommended storage buffers. For example, the magnetic beads from
Cytiva are temperature-stable, but should still be stored in optimal conditions for
assay consistency.
7
What does the future
hold for magnetic beads
in immunodiagnostics?
Magnetic beads are streamlining protein purification steps and are enhancing the
sensitivity and reliability of immunoassays. These powerful tools can also be used
across other immunodiagnostic workflow steps, including targeting nucleic acids and
cell surface proteins for cell enrichment and other clinical diagnostics purposes. For
example, magnetic beads can be used for: • Increased automation to enhance throughput and consistency of diagnostic
assays
• Precision biomarker detection, which can tailor treatments to individual
patients needs
• POC testing to detect a wider array of biomarkers including emerging diseases • Systems that use artificial intelligence and data analytics to improve
diagnostic accuracy and provide deeper insight to disease mechanisms
As precision diagnostics evolve, the use of magnetic beads in immunodiagnostics
promises to further streamline detection processes, improve assay sensitivity, and
reduce turnaround time. This advancement paints a bright future for healthcare, with
its potential to save resources, lower healthcare costs, and provide patients with
faster and more accurate diagnoses.
Ready to streamline your immunodiagnostic workflows? Browse Cytiva’s
full range of magnetic beads for proteins and immunoassays
8
References
1. Faye L, Grünwald-Gruber C, Vezina LP, Gomord V, Morel B. A fast and easy onestep purification strategy for plant-made antibodies using Protein A magnetic
beads. Front Plant Sci. 2023;14:1276148. doi:10.3389/FPLS.2023.1276148/BIBTEX
2. Hamedani NS, Happich FL, Klein EM, et al. Aptamer loaded superparamagnetic
beads for selective capturing and gentle release of activated protein C. Scientific
Reports 2022 12:1. 2022;12(1):1-11. doi:10.1038/s41598-022-11198-5
3. Chuang HY, Huang CC, Hung TC, et al. Development of biotinylated and magnetic
bead-immobilized enzymes for efficient glyco-engineering and isolation of
antibodies. Bioorg Chem. 2021;112:104863. doi:10.1016/J.BIOORG.2021.104863
4. Støy J, Olsen J, Park SY, Gregersen S, Hjørringgaard CU, Bell GI. In vivo
measurement and biological characterisation of the diabetes-associated mutant
insulin p.R46Q (GlnB22-insulin). Diabetologia. 2017;60(8):1423. doi:10.1007/
S00125-017-4295-2
5. Neukam M, Sala P, Brunner AD, et al. Purification of time-resolved insulin
granules reveals proteomic and lipidomic changes during granule aging. Cell Rep.
2024;43(3). doi:10.1016/J.CELREP.2024.113836/ASSET/37AC6EE1-2D42-4696-
8CE2-84FD0060EAC9/MAIN.ASSETS/GR2.JPG
6. Huergo LF, Selim KA, Conzentino MS, et al. Magnetic Bead-Based Immunoassay
Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2
Antibodies. ACS Sens. 2021;6(3):703-708. doi:10.1021/ACSSENSORS.0C02544/
SUPPL_FILE/SE0C02544_SI_002.MP4
7. Liu H, Shi Y, Ye J, et al. An automated magnetic beads-based chemiluminescence
immunoassay system for simultaneous quantification of multi-mycotoxins in
agricultural products. Sens Actuators B Chem. 2024;420:136424. doi:10.1016/J.
SNB.2024.136424
9
cytiva.com
Cytiva and the Drop logo are trademarks of Life Sciences IP Holdings Corporation
or an affiliate doing business as Cytiva. Sepharose and Sera-Mag are trademarks
of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva.
Any other trademarks are the property of their respective owners.
The Danaher trademark is a proprietary mark of Danaher Corporation.
© 2025 Cytiva
For local office contact information, visit cytiva.com/contact
CY49653-15May25-EB
Brought to you by

Download the eBook for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version